Related Experiment Video
Updated: Jan 21, 2026

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
Published on: February 14, 2022
Stroke Risk in Atrial Fibrillation: Beyond the CHA2DS2-VASc Score
Pooja S Jagadish1, Rajesh Kabra2
1Department of Internal Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.
Insights
Stroke prevention in atrial fibrillation (AF) management can be improved by considering novel risk factors beyond the CHA2DS2-VASc score. New models and markers offer enhanced stroke risk prediction for anticoagulation decisions.
Area of Science:
- Cardiology
- Neurology
- Internal Medicine
Background:
- Stroke prevention is critical in managing atrial fibrillation (AF).
- Current anticoagulation decisions rely on the CHA2DS2-VASc risk score.
- The need for improved stroke risk stratification in AF patients is recognized.
Purpose of the Study:
- To review novel risk factors for stroke in AF patients.
- To discuss alternative stroke prediction models beyond the CHA2DS2-VASc score.
- To explore enhanced strategies for anticoagulation decision-making in AF.
Main Methods:
- Review of clinical, laboratory, and imaging markers.
- Analysis of novel stroke prediction models (TIMI-AF, ATRIA, GARFIELD-AF).
- Evaluation of the impact of ethnicity on stroke risk prediction.
Main Results:
- Clinical markers (e.g., obstructive sleep apnea, renal failure) and laboratory markers (e.g., brain natriuretic peptide) predict stroke in AF.
- Imaging criteria (e.g., left atrial appendage morphology, spontaneous echo contrast) and coronary artery calcium score are relevant.
- Addition of African American ethnicity improves CHA2DS2-VASc stroke prediction in AF.
- Novel models like TIMI-AF, ATRIA, and GARFIELD-AF show potential for risk stratification.
Conclusions:
- The CHA2DS2-VASc score is the current standard for stroke risk stratification in AF.
- Integrating additional clinical, laboratory, and imaging markers can refine stroke risk assessment.
- Novel prediction models and consideration of ethnicity may enhance anticoagulation decisions for stroke prevention in AF.
Purpose Of Review:
Stroke prevention is the cornerstone of atrial fibrillation (AF) management and the anticoagulation decision is currently based on CHA2DS2-VASc risk score. We discuss several novel risk factors besides those included in CHA2DS2-VASc score and alternative models for stroke prediction.
Recent Findings:
Several clinical markers including obstructive sleep apnea and renal failure, laboratory markers like brain natriuretic peptide, imaging criteria including left atrial appendage morphology, spontaneous echo contrast, and coronary artery calcium score may predict stroke in AF patients. Addition of African American ethnicity to CHA2DS2-VASc score also improves stroke prediction in AF. Finally, novel models including TIMI-AF score, ATRIA score, and GARFIELD-AF scores have potential roles in risk stratification for stroke. While CHA2DS2-VASc score is the currently recommended risk stratification model for stroke prediction in AF, use of additional clinical, laboratory, imaging markers, ethnicity, and novel stroke prediction models may further assist in decision to anticoagulate the AF patient for stroke prevention.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Introduction to z Scores
z scores...
Introduction to z Scores
z scores...
z Scores and Area Under the Curve
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...

